These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25068277)

  • 1. A migrant left ventricular lead.
    Malagù M; Marcantoni L; Scalone A; Toselli T; Pratola C; Bertini M
    J Cardiovasc Med (Hagerstown); 2017 Oct; 18(10):782-783. PubMed ID: 25068277
    [No Abstract]   [Full Text] [Related]  

  • 2. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
    Pol Merkur Lekarski; 2017 Feb; 42(248):65-70. PubMed ID: 28258679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The evaluation of the ventricular arrhythmias and interventions of cardiac implantable electronic devices in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death in ambulatory and telemetric follow-up].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
    Pol Merkur Lekarski; 2017 Jan; 42(247):13-20. PubMed ID: 28134226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of myocardial viability on responsiveness to cardiac resynchronization in ischemic dilated cardiomyopathy: a prospective observational cohort study.
    Pugliese M; Minardi G; Vitali A; Natale E; De Girolamo P; Zampi G; Leggio M; Chiarelli A; Pappalardo A; Avella A; Laurenzi F; Fera MS
    Anadolu Kardiyol Derg; 2012 Mar; 12(2):132-41. PubMed ID: 22281793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrieval of a retained guide wire from the deltoid muscle-A rare and delayed presentation post cardiac resynchronization therapy lead replacement.
    Yadav VK; Jhanwar S; Goyal BM; Patel S
    J Card Surg; 2020 Oct; 35(10):2866-2868. PubMed ID: 32720320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and correctable but iatrogenic cause of loss of biventricular pacing: Physician awareness integrity failure.
    Cay S; Ozeke O; Ozcan F; Aras D; Topaloglu S
    Int J Cardiol; 2016 Nov; 223():425-427. PubMed ID: 27544599
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrical Triggers of Adverse Events During the Baseball World Series.
    Stolker JM; Aziz Z; Kennedy KF; Hauptman PJ
    Am J Cardiol; 2018 Nov; 122(10):1805-1806. PubMed ID: 30243462
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ventricular arrhythmias in dilated cardiomyopathy. Clinical and prognostic significance and the role of programmed electric stimulation].
    Raviele A
    G Ital Cardiol; 1991 Jan; 21(1):87-93. PubMed ID: 2055381
    [No Abstract]   [Full Text] [Related]  

  • 10. Atrial and ventricular lead switch at the pacemaker header: why did asystole first occur 3 years later?
    Al Hamdi A; Jastrzębski M; Hawas JM
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1431-3. PubMed ID: 23607502
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cardiac resynchronization therapy on right ventricular function--evaluation with tissue Doppler echocardiography.
    Santos JF; Caetano F; Parreira L; Madeira J; Cardoso P; Fonseca N; Segurado F; Soares LN; Inês L
    Rev Port Cardiol; 2003 Nov; 22(11):1347-55. PubMed ID: 14768490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worsening heart failure as the main manifestation of neglected complete extrusion of a cardiac resynchronization therapy pacemaker.
    Vassilikos VP; Mantziari AA; Stavropoulos G; Styliadis IH
    Cardiology; 2010; 117(4):243-5. PubMed ID: 21228592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue Doppler echocardiography for evaluation of patients with ventricular resynchronization therapy.
    Santos JF; Caetano F; Parreira L; Madeira J; Cardoso P; Fonseca N; Segurado F; Soares LN; Inês L
    Rev Port Cardiol; 2003 Nov; 22(11):1363-71. PubMed ID: 14768491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidence of ventricular arrhythmias and their correlation with sudden death in patients with idiopathic dilated myocardiopathy].
    Illanes G; González R; Corbalán R; Arriagada D; Fajuri A; Valenzuela P
    Rev Med Chil; 1984 Sep; 112(9):877-83. PubMed ID: 6543474
    [No Abstract]   [Full Text] [Related]  

  • 16. The Burden of Cardiac Rhythm Management Complications.
    Andrikopoulos GK
    Hellenic J Cardiol; 2016; 57(1):39-40. PubMed ID: 26856200
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous coronary vein angioplasty for severe spasm of the posterolateral vein during bi-ventricular pacing.
    Kapoor A; Kumar S; Batra A
    J Invasive Cardiol; 2011 Jul; 23(7):E170-2. PubMed ID: 21725134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk stratification of sudden cardiac death in dilated cardiomyopathy. Programmed ventricular stimulation].
    Bänsch D
    Herzschrittmacherther Elektrophysiol; 2015 Mar; 26(1):8-11. PubMed ID: 25693482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors related to infections of cardiac resynchronization therapy devices.
    Romeyer-Bouchard C; Da Costa A; Dauphinot V; Messier M; Bisch L; Samuel B; Lafond P; Ricci P; Isaaz K
    Eur Heart J; 2010 Jan; 31(2):203-10. PubMed ID: 19875388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices.
    Cano O; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
    Europace; 2011 Mar; 13(3):395-401. PubMed ID: 21131650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.